Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Despite the above, there are still a couple of silver linings that provide more than enough reason to be bullish about this stock.

Nvidia topping Apple as the most valuable company in the world and joining the Dow Jones Industrial Average. Why Novo Nordisk and Eli Lilly are giving totally different reads on the markets for GLP-1 ...

Discover the 50 ways Amazon has dived into healthcare in the past five-plus years, from launching Haven Healthcare to partnering with major health systems.

Discover the top 10 biggest companies in the world in 2024, featuring industry giants leading the global economy.

Probably the biggest objection to buying Lilly stock is its valuation. The big pharmaceutical company's shares trade at nearly 37.5 times forward earnings. Does this high multiple disqualify Lilly as ...

Drops for Big Tech companies including Microsoft and Facebook's parent company Meta Platforms led Wall Street lower.

On Thursday, Truist Securities adjusted its stock price target for Eli Lilly (NYSE:LLY) shares, bringing it down slightly to $1,029 from the previous $1,033 while still maintaining a Buy rating on ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other S&P 500 stocks. As per AXA Investment Managers, the US dominated financial markets this ...

Eli Lilly (NYSE: LLY) stock tanked after the company reported third-quarter results on Wednesday, Oct. 30. The report it issued before the opening bell was more than a little problematic.

What would a Harris or Trump presidency mean for health care policy? Why did Eli Lilly’s Mounjaro and Zepbound sales miss expectations? And does Adam believe in ghosts? We talk about all that an ...